


Searching News Database: MacroGenics
HSMN NewsFeed - 17 Jun 2021
KaliVir Immunotherapeutics Appoints Drs. Terry Hermiston and Jon Wigginton to Board of Directors
KaliVir Immunotherapeutics Appoints Drs. Terry Hermiston and Jon Wigginton to Board of Directors
HSMN NewsFeed - 15 Sep 2020
Partner Therapeutics (PTx) Announces the Appointment of Ed Rock as Chief Medical Officer
Partner Therapeutics (PTx) Announces the Appointment of Ed Rock as Chief Medical Officer
HSMN NewsFeed - 22 Apr 2016
BioMmune Appoints Dr. Patrick Gray as New Chief Executive Officer and President
BioMmune Appoints Dr. Patrick Gray as New Chief Executive Officer and President
HSMN NewsFeed - 19 Aug 2014
Dermira Completes $51 Million Financing and Expands Management Team and Board of Directors
Dermira Completes $51 Million Financing and Expands Management Team and Board of Directors
HSMN NewsFeed - 12 Aug 2013
MacroGenics Appoints Jon Wigginton, M.D., as Senior Vice President, Clinical Development
MacroGenics Appoints Jon Wigginton, M.D., as Senior Vice President, Clinical Development
HSMN NewsFeed - 6 May 2008
MacroGenics Appoints New Chief Commercial Officer and Chief Financial Officer
MacroGenics Appoints New Chief Commercial Officer and Chief Financial Officer
HSMN NewsFeed - 17 Dec 2007
Lilly and BioMS Medical Announce Global Licensing and Development Agreement
Lilly and BioMS Medical Announce Global Licensing and Development Agreement
HSMN NewsFeed - 10 Oct 2006
MacroGenics Receives Orphan Drug Designation From FDA for Monoclonal Antibody to Treat Type 1 Diabetes
MacroGenics Receives Orphan Drug Designation From FDA for Monoclonal Antibody to Treat Type 1 Diabetes
Additional items found! 1
Members Archive contains
1 additional stories matching:
MacroGenics
(Password required)
MacroGenics
(Password required)
